ACTRN12605000460606招募中1 期
A Phase I/II trial to evaluate the effects of allogeneic pegylated G-CSF mobilized stem cells in the treatment of haematological malignancy to inhibit the incidence of GVHD.
A/Prof Geoff Hill0 个研究点目标入组 47 人开始时间: 2005年9月22日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 70 Years（—）
- 性别
- All
入选标准
- •Diagnosis of haematological malignancy.Allogeneic peripheral blood stem cell transplant from an HLA identical sibling.Ablative conditioning regime (CY/TBI, BU/CY, FLU/MEL). ECOG performance status 0-2.Suitable HLA-identical sibling donor, fit for peripheral blood stem cell collection.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
2 期
An early phase II trial for efficacy and safety of TTA-121 on autism spectrum disorderAutism spectrum disorderJPRN-UMIN000031412Hamamatsu University School of Medicine, Department of Psychiatry144
进行中（未招募）
不适用
A phase II pilot trial to evaluate the efficacy of treatment with Pegilate G-CSF in a group of elderly patients AML without chemotherapy indications - NDEUCTR2006-006541-14-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
已完成
1 期
A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapyunresectable advanced colorectal cancerJPRN-UMIN000019876Takeda Pharmaceutical Company Limited52
进行中（未招募）
1 期
A phase II clinical trial to assess the effect of HC-SVT-1001 and HC-SVT-1002 in the surgical treatment of nonunions fractures of long bonesAtrophic pseudarthrosisMedDRA version: 21.1Level: PTClassification code 10048617Term: PseudarthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2013-000930-37-ESaboratorios Salvat, S.A.12
尚未招募
不适用
SIRT for metastatic pancreatic cancerACTRN12606000015549Sirtex Medical Limited10